Alfredo
García Layana
Publicacións nas que colabora con Alfredo García Layana (12)
2023
-
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration
Ophthalmology, Vol. 130, Núm. 6, pp. 588-597
2022
-
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
The Lancet, Vol. 399, Núm. 10326, pp. 729-740
-
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
The Lancet, Vol. 399, Núm. 10326, pp. 741-755
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
-
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Drugs and Aging, Vol. 32, Núm. 10, pp. 797-807
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
-
Do nutritional supplements have a role in age macular degeneration prevention?
Journal of Ophthalmology, Vol. 2014
2013
-
Smoking and age-related macular degeneration: Review and update
Journal of Ophthalmology, Vol. 2013
2011
-
Myopic choroidal neovascularization
Ophthalmology
2010
-
Guías de práctica clínica de la SERV: manejo de las oclusiones venosas de la retina
Archivos de la Sociedad Española de Oftalmologia, Vol. 85, Núm. 9, pp. 294-309
2009
-
Guías de práctica clínica de la SERV: Tratamiento de la degeneración macular asociada a la edad (DMAE) exudativa
Archivos de la Sociedad Española de Oftalmologia, Vol. 84, Núm. 7, pp. 333-344
2006
-
Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization
Acta Ophthalmologica Scandinavica, Vol. 84, Núm. 6, pp. 743-748